Hypertension, Vol 22, 682-687, Copyright © 1993 by American Heart Association
P Gohlke, V Lamberty, I Kuwer, S Bartenbach, A Schnell, W Linz, BA Scholkens, G Wiemer and T Unger
We investigated functional changes in aortic preparations of spontaneously
hypertensive rats treated in utero and subsequently up to 20 weeks of age
with the angiotensin converting enzyme (ACE) inhibitors ramipril (0.01 and
1 mg/kg per day) and perindopril (0.01 mg/kg per day). Early-onset
treatment with the high dose of ramipril inhibited aortic ACE activity,
prevented the development of hypertension, increased aortic vasodilator
responses to acetylcholine (10(-8) to 10(- 6) mol/L), decreased
vasoconstrictor responses to norepinephrine (10(- 8) mol/L), and increased
aortic cyclic GMP content by 160%. Low-dose ramipril inhibited aortic ACE
activity and attenuated the aortic vasoconstrictor response to
norepinephrine but had no effect on blood pressure. Low-dose treatment with
ramipril and perindopril resulted in a significant increase in aortic
cyclic GMP content by 98% and 77%, respectively. Long-term coadministration
of the bradykinin B2-receptor antagonist Hoe 140 abolished the ACE
inhibitor-induced increase in aortic cyclic GMP. Our data demonstrate that
long-term treatment with ACE inhibitors can alter vascular function of
compliance vessels independently of the antihypertensive action. The
increase in aortic cyclic GMP was due to bradykinin potentiating the action
of the ACE inhibitors.
ARTICLES
Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate
Department of Pharmacology, University of Heidelberg, Frankfurt, Germany.
This article has been cited by other articles:
![]() |
A. I. Vinik, T. Erbas, T. S. Park, K. B. Stansberry, J. A. Scanelli, and G. L. Pittenger Dermal Neurovascular Dysfunction in Type 2 Diabetes Diabetes Care, August 1, 2001; 24(8): 1468 - 1475. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Makino, M. Sugano, S. Ohtsuka, S. Sawada, and T. Hata Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats Cardiovasc Res, December 1, 1999; 44(3): 543 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zicha and J. Kunes Ontogenetic Aspects of Hypertension Development: Analysis in the Rat Physiol Rev, October 1, 1999; 79(4): 1227 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Linz, P. Wohlfart, B. A. Schoelkens, R. H. A. Becker, T. Malinski, and G. Wiemer Late Treatment With Ramipril Increases Survival in Old Spontaneously Hypertensive Rats Hypertension, August 1, 1999; 34(2): 291 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-E. Fabre, A. Rivard, M. Magner, M. Silver, and J. M. Isner Tissue Inhibition of Angiotensin-Converting Enzyme Activity Stimulates Angiogenesis In Vivo Circulation, June 15, 1999; 99(23): 3043 - 3049. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Partovian, A. Benetos, J.-P. Pommies, W. Mischler, and M. E. Safar Effects of a chronic high-salt diet on large artery structure: role of endogenous bradykinin Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1423 - H1428. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gohlke, C. Pees, and T. Unger AT2 Receptor Stimulation Increases Aortic Cyclic GMP in SHRSP by a Kinin-Dependent Mechanism Hypertension, January 1, 1998; 31(1): 349 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Linz, T. Jessen, R. H. A. Becker, B. A. Scholkens, and G. Wiemer Long-term ACE Inhibition Doubles Lifespan of Hypertensive Rats Circulation, November 4, 1997; 96(9): 3164 - 3172. [Abstract] [Full Text] |
||||
![]() |
A. Benetos, B. I. Levy, P. Lacolley, F. Taillard, M. Duriez, and M. E. Safar Role of Angiotensin II and Bradykinin on Aortic Collagen Following Converting Enzyme Inhibition in Spontaneously Hypertensive Rats Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3196 - 3201. [Abstract] [Full Text] |
||||
![]() |
G. Wiemer, W. Linz, S. Hatrik, B. A. Scholkens, and T. Malinski Angiotensin-Converting Enzyme Inhibition Alters Nitric Oxide and Superoxide Release in Normotensive and Hypertensive Rats Hypertension, November 1, 1997; 30(5): 1183 - 1190. [Abstract] [Full Text] |
||||
![]() |
N. Makino, M. Sugano, S. Otsuka, and T. Hata Molecular Mechanism of Angiotensin II Type I and Type II Receptors in Cardiac Hypertrophy of Spontaneously Hypertensive Rats Hypertension, October 1, 1997; 30(4): 796 - 802. [Abstract] [Full Text] |
||||
![]() |
P. Gohlke, I. Kuwer, A. Schnell, K. Amann, G. Mall, and T. Unger Blockade of Bradykinin B2 Receptors Prevents the Increase in Capillary Density Induced by Chronic Angiotensin-Converting Enzyme Inhibitor Treatment in Stroke-Prone Spontaneously Hypertensive Rats Hypertension, January 1, 1997; 29(1): 478 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hutri-Kahonen, M. Kahonen, J.-P. Tolvanen, W. Xiumin, K. Sallinen, and I. Porsti Ramipril therapy improves arterial dilation in experimental hypertension Cardiovasc Res, January 1, 1997; 33(1): 188 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gohlke, W. Linz, B. A. Scholkens, G. Wiemer, and T. Unger Cardiac and Vascular Effects of Long-term Losartan Treatment in Stroke-Prone Spontaneously Hypertensive Rats Hypertension, September 1, 1996; 28(3): 397 - 402. [Abstract] [Full Text] |
||||
![]() |
A. Mimran, J. Ribstein, and G. DuCailar Contrasting Effect of Antihypertensive Treatment on the Renal Response to L-Arginine Hypertension, December 1, 1995; 26(6): 937 - 941. [Abstract] [Full Text] |
||||
![]() |
R. D. Paula, C. V. Lima, M. C. Khosla, and R. A.S. Santos Angiotensin-(1-7) Potentiates the Hypotensive Effect of Bradykinin in Conscious Rats Hypertension, December 1, 1995; 26(6): 1154 - 1159. [Abstract] [Full Text] |
||||
![]() |
G. Berkenboom, D. Brekine, P. Unger, K. Grosfils, M. Staroukine, and J. Fontaine Chronic Angiotensin-Converting Enzyme Inhibition and Endothelial Function of Rat Aorta Hypertension, November 1, 1995; 26(5): 738 - 743. [Abstract] [Full Text] |
||||
![]() |
D. Rizzoni, M. Castellano, E. Porteri, G. Bettoni, M. L. Muiesan, A. Cinelli, and E. A. Rosei Effects of Low and High Doses of Fosinopril on the Structure and Function of Resistance Arteries Hypertension, July 1, 1995; 26(1): 118 - 123. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |